The aim of the present systematic review and meta-analysis is the exploration of the potential evidence of the effectiveness of aromatherapy products on the sexual function of menopausal women. Methods: From inception to December 2017, the search process was performed using the MEDLINE and Scopus databases and the Cochrane Library regarding the trials on the effectiveness of herbal-medicine aromatherapy on the sexual function of menopausal women. Results: Three of the trials comprise suitable data for inclusion in the meta-analysis. According to the meta-analysis, it is possible to improve the standardized mean difference (SMD) of the sexual desire up to 0.56 in the aromatherapy group compared with the control group (SMD = 0.56; P < 0.001; heterogeneity; I 2 = 42%; P = 0.141). According to one of the trials, the serum-estrogen level of two different doses did not change in the neroli oil inhalation group compared with the almond-oil group. Conclusions: Both aromatherapy with neroli oil or lavender (monopreparation) and combined-oil aromatherapy with lavender, fennel, geranium, and rose significantly improved human sexual function; however, a significant change of the serum-estrogen level was not detected. The findings of the present review should be presented cautiously because of the corresponding limitations such as the lack of a standardized tool, the lack of intention-to-treat reporting, the low study amount, and the short-term followup. Accordingly, the purpose of current systematic review and meta-analysis was to evaluate the effect of aromatherapy on relieving some sexual function.
Introduction
Menopause is a natural biological process affecting the lives of all women. 1 Following the increased life expectancy and the stabilization of menopause, women continue to live in the post-menopausal period about more than one-third of the rest of their lives; therefore, it is essential to maintain the welfare of women during this period as a top priority in preventing socioeconomical risks. 2~4 A dramatic decline in both circulating estrogen and androgen levels with age during natural menopause period can render various sexual dysfunction, including little enthusiasm, poor arousal, dyspareunia, impaired orgasm and reduced satisfaction. 5 The estrogen therapy may attenuate such impairments and improve urogenital atrophy sexual performance. 6~8 In earlier times, one of the prevalent recommended remedies was
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Materials and Methods
The main study objective was to identify the effect of aromatherapy on sexual problem among menopausal women.
The study was conducted on the published randomized controlled trials. The inclusion criteria were perimenopausal and postmenopausal women, study design of parallel or crossover groups, reported sexual symptoms and taking herbal medicines for aromatherapy. 
Results
Process of selecting of included articles to systematic review ( Fig. 1) . Nikjou et al. 2 conducted a crossover study and compared the effect of lavender aromatherapy (n = 50) with placebo (n = 50) on the sexual desire among the menopausal women, who suffered from hot flush symptoms with Green score of 15 to 42. The demographic profiles such as The ANCOVA results showed an increase in total score (P < 0.001) and subscales such as libido (P < 0.01), sexual arousal (P < 0.01), vaginal lubricating (P < 0.01), orgasms (P < 0.01), sexual satisfaction (P < 0.01) in the aromatherapy group (n = 57) compared to the placebo group (n = 57). Paired ttest used to pre-and post-tests was significant for the total score (P < 0.001) and all subscales of libido (P < 0.001), sexual arousal (P < 0.001), vaginal lubricant (P < 0.001), orgasm (P < 0.001) and sexual satisfaction (P < 0.001), except for dyspareunia (P = 0.24). In the placebo group, the difference in the pre-and post-tests was also significant for total score, libido sexual arousal and dyspareunia. Furthermore, 7% and 5.1% of the subjects in the intervention group showed no significant difference between three groups regarding sexual domain of MENQOL. However, the sexual desire measured by VAS was different between the three groups. The ANOVA were followed by post hoc analysis and the results revealed that both low and high doses were more effective compared to the control group. The serum estrogen level were not different between the three groups (n = 63; P = 0.270).
Three trials 2, 6, 13 had suitable data to include in the metaanalysis. Our meta-analysis showed that SMD of the sexual desire could be improved up to 0.5 in the aromatherapy group compared to the control group (SMD = 0.56; P < 0.001; heterogeneity; I 2 = 42%; P = 0.141) (Fig. 2) .
Discussion
The present systematic review scrutinized the efficacy and Choi et al. 13 reported that the inhalation of neroli (at the concentrations of 1% and 0.5%) caused a statistically significant improvement in the sexual desire VAS score compared with the almond oil, whereas this significant change was not observed regarding score of sexual domain of MENQOL.
The sexual domain of MENQOL consists of three items, including vaginal dryness, and two items related to sexual functions of "decrease in my sexual desire" and "avoiding intimacy" . Explained discrepancy between the results of two scale may related to this reason that the inhalation of oil are Although we think that our search strategy was comprehensive but it is possible to be failed to detect some studies.
Only 
Conclusion
Aromatherapy with neroli oil or lavender (mono-preparation) and combined aromatherapy oils of lavender, fennel, geranium and rose significantly improved sexual function.
However, there was no significant change in serum estrogen level. These findings should be presented cautiously because of limitations in this review such as lack of standardized tool, lack of reporting ITT, low number of studies and short-term follow-up.
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